LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition

被引:30
作者
Tolloczko, B [1 ]
Turkewitsch, P [1 ]
Al-Chalabi, M [1 ]
Martin, JG [1 ]
机构
[1] McGill Univ, Meakins Christie Labs, Montreal, PQ H2 2P2, Canada
关键词
D O I
10.1124/jpet.104.069013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Phosphoinositide 3-kinase (PI3K) may potentially influence intracellular [Ca2+](i) concentration by several mechanisms. We have investigated the effects of phosphoinositide 3-kinase (PI3K) inhibitors wortmannin and LY-294002 [2-(4-morpholinyl)-8- phenyl-4H-1-benzopyran-4-one] on Ca2+ signaling in rat airway smooth muscle (ASM) cells using fura-2 and imaging methodology. Wortmannin ( 1 muM) and LY-294002 ( 1 and 10 muM) had opposite effects: wortmannin caused a small increase, whereas LY-294002 caused a significant decrease of peak Ca2+ responses to serotonin (5-HT). LY-294002 ( 10 muM) diminished 5-HT-induced ASM cell contraction, measured as a change in cell surface area, and inositol phosphate formation, measured by anion exchange chromatography. Thin layer chromatography revealed that the levels of phospholipase C ( PLC) substrate phosphatidylinositol 4,5-bisphosphate were not affected. SDS polyacrylamide gel electrophoresis and Western blotting have shown that both wortmannin and LY-294002 inhibited platelet-derived growth factor-induced PI3K activation. However, PI3K activation could not be detected after 5-HT stimulation. The specific casein kinase-2 (CK2) inhibitor 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole ( 10 - 40 muM) reduced 5-HT-triggered responses to a similar extent as LY-294002. We conclude that LY-294002 modulates Ca2+ signaling in rat ASM independently of its action on PI3K by acting on, or upstream of, PLC, possibly by inhibiting CK2.
引用
收藏
页码:787 / 793
页数:7
相关论文
共 38 条
[1]  
Banes A, 1999, J PHARMACOL EXP THER, V291, P1179
[2]   IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner [J].
Blair, LAC ;
Marshall, J .
NEURON, 1997, 19 (02) :421-429
[3]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[4]  
Carpenter KA, 1997, BIOPOLYMERS, V42, P37, DOI 10.1002/(SICI)1097-0282(199707)42:1<37::AID-BIP4>3.0.CO
[5]  
2-2
[6]  
Coffer PJ, 1998, BIOCHEM J, V335, P1
[7]   The yeast and mammalian isoforms of phosphatidylinositol transfer protein can all restore phospholipase C-mediated inositol lipid signaling in cytosol-depleted RBL-2H3 and HL-60 cells [J].
Cunningham, E ;
Tan, SK ;
Swigart, P ;
Hsuan, J ;
Bankaitis, V ;
Cockcroft, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) :6589-6593
[8]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[9]   Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity [J].
Donella-Deana, A ;
Cesaro, L ;
Sarno, S ;
Ruzzene, M ;
Brunati, AM ;
Marin, O ;
Vilk, G ;
Doherty-Kirby, A ;
Lajoie, G ;
Litchfield, DW ;
Pinna, LA .
BIOCHEMICAL JOURNAL, 2003, 372 (03) :841-849
[10]   Activation of phospholipase Cγ by PI 3-kinase-induced PH domain-mediated membrane targeting [J].
Falasca, M ;
Logan, SK ;
Lehto, VP ;
Baccante, G ;
Lemmon, MA ;
Schlessinger, J .
EMBO JOURNAL, 1998, 17 (02) :414-422